Science journalism by Leonid Schneider, on research integrity and academic publishing in life sciences and biomedicine
EU Commission gives €6 million to an obscure German start-up, promising to convert sewage to synthetic fuels. Internet sources suggest behind all this is “Professor” Ruggiero Santilli, the litigious “Florida Genius”, eternally self-appointed Nobel Prize candidate and sock-
puppeteering businessman. Exactly the kind of “fringe scientist” Smut Clyde likes to write about!
Telomere dysfunction is a common problem in older men. Dr Shai Efrati can help: Book your appointment for Hyperbaric Oxygen Therapy now!
There is a miracle drug for COVID-19, but it is secret. Enterprising researchers at Institute Pasteur in Lille ask for €5 million.
Jan van Deursen had to resign from Mayo Clinic over bullying charges. With his company Unity Biotech’s phase 2 clinical trial failed, stock devalued and staff laid-off, van Deursen sued me in German court about the reproducibility of his senolytics research.
As a young Wunderkind, Josef Penninger discovered the ACE2 receptor. Now he invented the cure for the coronavirus which will work in his hands where Big Pharma failed. He was never found guilty of research misconduct and never retracted a paper. Dr Penninger is a Genius making a COVID-19 vaccine.
Science communication by press release. No paper is published, no data available, but a Max Planck Institute director is eager to announce a possible cure for COVID-19: artemisia extracts, by his own company.
Scientists David Sinclair and Michael Lisanti have an ingenious solution to COVID-19: anti-aging drugs. If a disease kills old people, stop being old!
Another instalment of grifting quackery in COVID-19 pandemic. Cedars-Sinai scientists and their biotech partners Aytu Biosciences want to light you up from inside, just as President Trump suggested.
Israeli scientists discovered a cure for coronavirus! Their proprietary PLX cells from placenta deliver 100% survival rate both against COVID-19 and a nuclear holocaust. The stocks soar.
In this 3rd instalment of her Celixir investigation, Patricia Murray learns whose side the British authority MHRA is on. Not the patients’, and certainly not on the side of facts.
